cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Oric Pharmaceuticals
9 own
11 watching
Current Price
$6.13
$0.28
(4.79%)
logo-oric
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
242.6M
52-Week High
52-Week High
9.93
52-Week Low
52-Week Low
2.36
Average Volume
Average Volume
0.15M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization242.6M
icon52-Week High9.93
icon52-Week Low2.36
iconAverage Volume0.15M
iconDividend Yield--
iconP/E Ratio--
What does the Oric Pharmaceuticals do?
ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. Profound advancements in oncology drug development have expanded the treatment options available to patients, yet therapeutic resistance and relapse continue to limit the efficacy and duration of clinical benefit of such treatments. Collectively, our founders and management team have a decades-long heritage of identifying and characterizing resistance mechanisms in oncology, having discovered and developed groundbreaking medicines at companies such as Ignyta, Medivation, Aragon and Genentech. At ORIC, our fully integrated discovery and development team is advancing a diverse pipeline of innovative therapies designed to counter resistance mechanisms in cancer by leveraging our expertise within three specific areas: hormone-dependent cancers, precision oncology and key tumor dependencies. We were incorporated in Delaware in August 2014. Our principal executive offices are located at 240 E. Grand Avenue, 2nd Floor, South San Francisco, California 94080. Our telephone number is (650) 388-5600.Our website address is www.oricpharma.com.
Read More
How much money does Oric Pharmaceuticals make?
News & Events about Oric Pharmaceuticals.
Globe Newswire
19days ago
Initial Phase 1b data for three ongoing clinical trials expected in second half of 2023:ORIC-533 in multiple myeloma, ORIC-114 in EGFR/HER2-mutated cancers, and ORIC-944 in prostate cancer Development candidate selected for PLK4 synthetic lethal breast cancer program Cash and investments of $228 ...
PR Newswire
1month ago
Thinking about buying stock in Thermogenesis Holdings, ProQR Therapeutics, Grom Social, ORIC Pharmaceuticals, or Acasti Pharma? Thinking about buying stock in Thermogenesis Holdings, ProQR Therapeutics, Grom Social, ORIC Pharmaceuticals, or Acasti Pharma? PR Newswire NEW YORK, Dec. 22, 2022 NEW...
Globe Newswire
1month ago
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Dec. 13, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, presented preclinical ORIC-533 data demonstrating a potential ...
Globe Newswire
2 months ago
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced a preclinical poster presentation on ORIC-533 ...
Ticker Report
10 months ago
ORIC Pharmaceuticals (NASDAQ:ORIC Get Rating) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a note issued to investors on Wednesday, Zacks.com reports. According to Zacks, ORIC Pharmaceuticals Inc. is a clinical stage ...
Frequently Asked Questions
Frequently Asked Questions
What is Oric Pharmaceuticals share price today?
plus_minus_icon
Can Indians buy Oric Pharmaceuticals shares?
plus_minus_icon
How can I buy Oric Pharmaceuticals shares from India?
plus_minus_icon
Can Fractional shares of Oric Pharmaceuticals be purchased?
plus_minus_icon
What are the documents required to start investing in Oric Pharmaceuticals stocks?
plus_minus_icon
What is today’s traded volume of Oric Pharmaceuticals?
plus_minus_icon
What is today’s market capitalisation of Oric Pharmaceuticals?
plus_minus_icon
What is the 52-Week High and Low Range of Oric Pharmaceuticals?
plus_minus_icon
What percentage is Oric Pharmaceuticals down from its 52-Week High?
plus_minus_icon
What percentage is Oric Pharmaceuticals up from its 52-Week Low?
plus_minus_icon
Current Price
$6.13
$0.28
(4.79%)
logo-oric
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00